These two healthcare ETFs take fundamentally different approaches to investing, with meaningful differences in diversification, management strategy, and long-term return potential.
The VanEck Semiconductor ETF's slump is nasty, but could prove to be a compelling buying opportunity.
Motley Fool Press Release.
VanEck's concentrated 26-stock portfolio delivered stronger five-year returns and lower volatility, while State Street's 62-holding fund offers broader diversification and lower fees.
The rule fired again in July. How much should investors trust a 7-for-8 record?
BBH offers lower costs and concentrated large-cap exposure, while PBE delivers higher dividend income and slightly better five-year returns through a multifactor strategy.
IHE has outperformed recently by concentrating in U.S. drugmakers. PPH offers global reach and a higher dividend for investors willing to trade some of that momentum for income.
These two healthcare ETFs offer investors exposure to some of medicine's biggest names, but their different approaches to investing could lead to very different results.
VanEck's uranium fund yields 3.1% but lost 28% last year, while iShares' renewable portfolio gained 8.3% with lower costs.
VanEck offers lower costs and higher dividends with a concentrated pharma focus, while Simplify provides broader healthcare exposure and donates profits to breast cancer research.
Physical silver offers lower costs and no dividend, while gold miners provide equity diversification and income. Which metals strategy fits your portfolio?
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings.
BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their five-year returns diverged significantly.
State Street's oil and gas fund surged 43.6% in one year while the nuclear fund declined 24.8%, yet both delivered similar five-year growth.
VanEck offers lower costs and double the dividend yield, while Invesco delivered stronger 1-year returns with more balanced holdings.
This semiconductor ETF continues to look ripe for more gains.
Detailed price information for Broadcom Ltd (AVGO-Q) from The Globe and Mail including charting and trades.
PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns.
SCHO charges half VanEck's fee while delivering a 1.09 percentage point yield advantage and stronger five-year returns.
VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher dividend yield and stronger five-year returns.
Sprott offers lower fees and higher dividend yield, while VanEck commands $31 billion in assets with broader global exposure to mining companies.
VanEck's concentrated 25-stock approach offers higher individual company exposure, while Invesco's broader 251-position portfolio delivered 47.4% returns over the past year.
This is the newest page. Registered accounts read further back.